INCOBOTULINUMTOXINA TO TREAT SIALORRHEA IN PARKINSON'S DISEASE: A REAL-LIFE STUDY

被引:0
|
作者
Bergmans, B. [1 ,2 ]
Schotte, V. [1 ]
Sys, N. [3 ]
Van Massenhove, E. [1 ]
Van Zandijcke, M. [4 ]
机构
[1] AZ Sint Jan Brugge Oostende AV, Neurol, Brugge, Belgium
[2] Ghent Univ Hosp, Neurol, Ghent, Belgium
[3] AZ Sint Jan Brugge Oostende AV, Pharm, Brugge, Belgium
[4] AZ Zeno, Neurol, Knokke, Belgium
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 237
引用
收藏
页码:E69 / E70
页数:2
相关论文
共 50 条
  • [41] Impact of motor fluctuations on real-life gait in Parkinson's patients
    Silva de Lima, Ana Ligia
    Evers, Luc J. W.
    Hahn, Tim
    de Vries, Nienke M.
    Daeschler, Margaret
    Boroojerdi, Babak
    Terricabras, Dolors
    Little, Max A.
    Bloem, Bastiaan R.
    Faber, Marjan J.
    [J]. GAIT & POSTURE, 2018, 62 : 388 - 394
  • [42] Botulinum toxin for Sialorrhea in Patients with Parkinson's disease & Atypical Parkinsonism: A Single Center Real-World Study
    Buttar, Danyaal
    Siddiqui, Mustafa
    [J]. NEUROLOGY, 2023, 100 (17)
  • [43] Glycopyrrolate as inhalation for treating sialorrhea in Parkinson's Disease
    Velzen, L.
    Masselink, J.
    Dorresteijn, L.
    Movig, K.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S667 - S668
  • [44] Real-life evaluations of compliance with mandatory drug safety monitoring exemplified with tolcapone in Parkinson's disease
    Unger, Marcus M.
    Reese, Jens P.
    Oertel, Wolfgang H.
    Eggert, Karla M.
    [J]. EUROPEAN NEUROLOGY, 2008, 60 (03) : 122 - 126
  • [45] Real-life heart rate assessment: a digital biomarker for autonomic dysfunction in early Parkinson's disease?
    Veldkamp, K.
    Evers, L.
    Raykov, Y.
    Little, M.
    Brouwer, M.
    Bloem, B.
    Thannhauser, J.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S796 - S796
  • [46] Levodopa responsiveness in Parkinson’s disease: harnessing real-life experience with machine-learning analysis
    Ruth Djaldetti
    Ben Hadad
    Johnathan Reiner
    Bella Askenazi Kharash
    Boaz Lerner
    [J]. Journal of Neural Transmission, 2022, 129 : 1289 - 1297
  • [47] A retrospective "real-life" study of pramipexole tolerability in young and old Parkinson's disease patients attending Movement Disorders clinic
    Kwan, L
    Dhawan, V
    Forbes, A
    Brand, G
    Chaudhuri, KR
    [J]. MOVEMENT DISORDERS, 2005, 20 : S45 - S46
  • [48] Levodopa responsiveness in Parkinson's disease: harnessing real-life experience with machine-learning analysis
    Djaldetti, Ruth
    Hadad, Ben
    Reiner, Johnathan
    Kharash, Bella Askenazi
    Lerner, Boaz
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (10) : 1289 - 1297
  • [49] Does a clinical study reflect real-life and real-life costs
    Juhl, HH
    Hvenegaard, A
    Schmidt, VM
    Habicht, A
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 373 - 374
  • [50] CAMPTOCORMIA TREATMENT WITH INCOBOTULINUMTOXINA (XEOMIN®) IN PATIENTS WITH PARKINSON'S DISEASE
    Kovalenko, Alexandr
    Zakharov, Denis
    Fursova, Irina
    Misikov, Victor
    Tolmacheva, Violetta
    [J]. TOXICON, 2018, 156 : S63 - S63